Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “First Line Metastatic Colorectal Cancer”

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT06115733
What this trial is testing

Study of Fuquinitinib Combined With Capecitabine First-line Maintenance in the Treatment of Metastatic Colorectal Cancer

Who this might be right for
Colorectal Carcinoma
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 56
Testing effectiveness (Phase 2)UnknownNCT05022030
What this trial is testing

First-line mCapOX+Cetuximab vs. mFOLFOX6+Cetuximab for Metastatic Left-sided CRC With Wild-type RAS/BRAF Genes

Who this might be right for
Colo-rectal CancerCapecitabineCetuximab
West China Hospital 150
Large-scale testing (Phase 3)Study completedNCT00305188
What this trial is testing

Evaluation of the Efficacy of Xaliproden (SR57746A) in Preventing the Neurotoxicity of Oxaliplatin / 5FU/LV Chemotherapy.

Who this might be right for
MetastasesColorectal NeoplasmsColorectal Carcinoma
Sanofi 879
Testing effectiveness (Phase 2)Study completedNCT02138617
What this trial is testing

Genotype-Directed Study Of Irinotecan Dosing In FOLFIRI + BevacizumabTreated Metastatic Colorectal Cancer

Who this might be right for
Colon Cancer
UNC Lineberger Comprehensive Cancer Center 100
Testing effectiveness (Phase 2)WithdrawnNCT02085005
What this trial is testing

Capecitabine Plus Aflibercept as Maintenance Therapy Following Capecitabine Plus Oxaliplatin Plus Aflibercept in Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer Metastatic
Sanofi
Not applicableEnded earlyNCT01098422
What this trial is testing

Yttrium-90 Radioactive Resin Microspheres to Treat Colorectal Adenocarcinoma Metastatic to the Liver

Who this might be right for
Colorectal NeoplasmsLiver Neoplasms
Tony Reid, M.D., Ph.D. 10
Testing effectiveness (Phase 2)Study completedNCT00862342
What this trial is testing

Post-First Progression Use of Bevacizumab in Metastatic Colorectal Cancer (mCRC)

Who this might be right for
Metastatic Colorectal Cancer
Asan Medical Center 78
Testing effectiveness (Phase 2)Study completedNCT00778102
What this trial is testing

Avastin (Bevacizumab) in Combination With mFOLFOX-6 or FOLFOXIRI in Patients With Metastatic Colorectal Cancer.

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche 80
Testing effectiveness (Phase 2)Ended earlyNCT00588900
What this trial is testing

Irinotecan and Cediranib in Treating Patients With Metastatic Colorectal Cancer That Did Not Respond to Previous Oxaliplatin, Fluoropyrimidine, and Bevacizumab

Who this might be right for
Colorectal Cancer
Alliance for Clinical Trials in Oncology 5
Testing effectiveness (Phase 2)Study completedNCT01328171
What this trial is testing

FOLFOXIRI With or Without Panitumumab in Metastatic Colorectal Cancer (VOLFI)

Who this might be right for
Metastatic Colorectal Cancer
AIO-Studien-gGmbH 93
Testing effectiveness (Phase 2)UnknownNCT01144195
What this trial is testing

A Clinical Trial of Panitumumab in Combination With FOLFIRI Chemotherapy as Second Line Treatment in Subjects With Metastatic Colorectal Cancer Expressing Wild-type KRAS and Who Had Progressed ≥ 6 Months After the Last Dose of the First Line Chemotherapy

Who this might be right for
Metastatic Colorectal Cancer
Associacio catalana per a la recerca oncologica i les seves implicacions sanitaries i socials 80
Testing effectiveness (Phase 2)Study completedNCT01251536
What this trial is testing

Cetuximab Standard or Dose Escalation in First Line Colorectal Cancer

Who this might be right for
Colorectal Cancer
Universitaire Ziekenhuizen KU Leuven 108
Testing effectiveness (Phase 2)WithdrawnNCT01175291
What this trial is testing

FOLFOX/Bevacizumab +/- MK-0646 in Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
H. Lee Moffitt Cancer Center and Research Institute
Testing effectiveness (Phase 2)Study completedNCT00030797
What this trial is testing

Combination Chemotherapy in Treating Patients With Advanced or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Swiss Cancer Institute 75
Early research (Phase 1)Study completedNCT00940758
What this trial is testing

Phase I and Pharmacokinetic Study of Biweekly PEP02 in mCRC Refractory to 1st-line Oxaliplatin Base Therapy

Who this might be right for
Metastatic Colorectal Cancer
PharmaEngine 18
Testing effectiveness (Phase 2)UnknownNCT02128425
What this trial is testing

FOLFOXIRI Compared to FOLFOX in First Line Treatment of Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Sun Yat-sen University 162
Large-scale testing (Phase 3)Study completedNCT00700102
What this trial is testing

Avastin (Bevacizumab) Plus Crossover Fluoropyrimidine-Based Chemotherapy in Patients With Metastatic Colorectal Cancer.

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche 820
Testing effectiveness (Phase 2)Study completedNCT01225744
What this trial is testing

Erbitux Study of CPT11, Oxaliplatin, UFToral Targeted Therapy

Who this might be right for
Metastatic Colorectal Cancer
The Christie NHS Foundation Trust 47
Testing effectiveness (Phase 2)Study completedNCT00640081
What this trial is testing

Combination Chemotherapy and Cetuximab as First-Line Therapy in Treating Patients With Advanced and/or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Cheryl Pugh 169
Testing effectiveness (Phase 2)Looking for participantsNCT06978400
What this trial is testing

Dabrafenib Plus Cetuximab/Panitumumab With FOLFOX in the First Line of Therapy in People With Metastatic Colorectal Cancer

Who this might be right for
Neoplasms
Blokhin's Russian Cancer Research Center 64
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation